P-228 Use of cilta-cel CAR T cells following previous use of a BCMA-directed CAR T-cell product in heavily treated patients with relapsed/refractory multiple myeloma: a single institution case series

Autor:	Attar, Narsis, Cirstea, Diana, Branagan, Andrew, Yee, Andrew, Frigault, Matthew, Raje, Noopur
Zdroj:	In Clinical Lymphoma, Myeloma and Leukemia September 2023 23 Supplement 2:S161-S161
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect